(Q77466437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

G R Tennvall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J O Fernberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

129-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02989592

5 December 2019

exact match

0 references

cites work

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

1 reference

12 December 2020

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

12 December 2020

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

12 December 2020

European experience with ifosfamide in non-small cell lung cancer.

1 reference

12 December 2020

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

1 reference

12 December 2020

Overview of empiric antibiotic therapy for the febrile neutropenic patient

1 reference

12 December 2020

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium

1 reference

12 December 2020

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 reference

12 December 2020

Ifosfamide in the treatment of non-small cell lung cancer

1 reference

12 December 2020

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

12 December 2020

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force

1 reference

12 December 2020

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study

1 reference

12 December 2020

[Centralized compounding of cytostatics results in better service and lower cost]

1 reference

12 December 2020

Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups

1 reference

12 December 2020

The impact of cytotoxic chemotherapy - perspectives from patients, specialists and nurses

1 reference

12 December 2020

Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package

1 reference

12 December 2020

Justification of a pharmacy intravenous admixture service in an Australian hospital.

1 reference

12 December 2020

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

1 reference

12 December 2020

Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: an overview.

1 reference

12 December 2020

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

1 reference

12 December 2020

Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer

1 reference

12 December 2020

Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer

1 reference

12 December 2020

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

12 December 2020